Center Laboratories, Inc. (TPEX:4123)
Taiwan · Delayed Price · Currency is TWD 39.75
-0.65 (-1.61%)
Apr 20, 2026, 1:24 PM CST
Center Laboratories Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,516 | 1,618 | 1,394 | 767.72 | 500.11 | |
Revenue Growth (YoY) | -6.29% | 16.06% | 81.58% | 53.51% | -30.25% |
Cost of Revenue | 894.93 | 868.92 | 775.91 | 361.45 | 240.45 |
Gross Profit | 621.26 | 748.95 | 618.09 | 406.27 | 259.66 |
Selling, General & Admin | 449.67 | 442.67 | 456.8 | 287.34 | 291.4 |
Research & Development | 84.78 | 71.96 | 82.76 | 47.02 | 75.4 |
Other Operating Expenses | 448.88 | - | - | -212.52 | 147.02 |
Operating Expenses | 982.88 | 514.89 | 539.54 | 122.15 | 513.81 |
Operating Income | -361.62 | 234.06 | 78.56 | 284.12 | -254.15 |
Interest Expense | -182.42 | -199.12 | -173.65 | -75.82 | -94.07 |
Interest & Investment Income | 117.35 | 175.02 | 332.1 | 201.78 | 222.01 |
Earnings From Equity Investments | -198.16 | -549.02 | -720.99 | -705.7 | 983.24 |
Currency Exchange Gain (Loss) | -58.15 | 76.95 | -1.4 | 319.61 | 5.15 |
Other Non Operating Income (Expenses) | 40.23 | 27.38 | -35.51 | 24.98 | 79.73 |
EBT Excluding Unusual Items | -642.77 | -234.73 | -520.89 | 48.97 | 941.91 |
Gain (Loss) on Sale of Investments | 12,211 | -935.33 | -590.64 | -637.85 | 1,654 |
Gain (Loss) on Sale of Assets | - | 0.02 | - | - | - |
Asset Writedown | - | - | -2.38 | -0.03 | - |
Pretax Income | 11,569 | -1,170 | -1,114 | -588.91 | 2,596 |
Income Tax Expense | 2,246 | -66.63 | -66.26 | -13.29 | 438.69 |
Earnings From Continuing Operations | 9,323 | -1,103 | -1,048 | -575.62 | 2,157 |
Minority Interest in Earnings | - | -0.28 | 52.23 | 677.84 | -340.77 |
Net Income | 9,323 | -1,104 | -995.42 | 102.22 | 1,816 |
Net Income to Common | 9,323 | -1,104 | -995.42 | 102.22 | 1,816 |
Net Income Growth | - | - | - | -94.37% | -52.03% |
Shares Outstanding (Basic) | 756 | 746 | 698 | 677 | 667 |
Shares Outstanding (Diluted) | 822 | 746 | 698 | 677 | 700 |
Shares Change (YoY) | 10.19% | 6.91% | 2.98% | -3.27% | 3.96% |
EPS (Basic) | 12.33 | -1.48 | -1.43 | 0.15 | 2.72 |
EPS (Diluted) | 11.44 | -1.48 | -1.43 | 0.15 | 2.64 |
EPS Growth | - | - | - | -94.29% | -53.20% |
Free Cash Flow | -178.34 | 220.56 | -1,133 | -197.16 | -365.69 |
Free Cash Flow Per Share | -0.22 | 0.30 | -1.62 | -0.29 | -0.52 |
Dividend Per Share | - | 0.750 | 1.428 | 0.866 | 1.889 |
Dividend Growth | - | -47.46% | 64.87% | -54.16% | 83.29% |
Gross Margin | 40.98% | 46.29% | 44.34% | 52.92% | 51.92% |
Operating Margin | -23.85% | 14.47% | 5.63% | 37.01% | -50.82% |
Profit Margin | 614.88% | -68.22% | -71.41% | 13.31% | 363.16% |
Free Cash Flow Margin | -11.76% | 13.63% | -81.27% | -25.68% | -73.12% |
EBITDA | -200.93 | 383.25 | 216 | 315.09 | -220.84 |
EBITDA Margin | -13.25% | 23.69% | 15.50% | 41.04% | -44.16% |
D&A For EBITDA | 160.69 | 149.19 | 137.44 | 30.97 | 33.31 |
EBIT | -361.62 | 234.06 | 78.56 | 284.12 | -254.15 |
EBIT Margin | -23.85% | 14.47% | 5.63% | 37.01% | -50.82% |
Effective Tax Rate | 19.41% | - | - | - | 16.90% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.